Repligen, an innovative leader in bioprocess technology, has made a strategic move by acquiring essential upstream Process Analytical Technology (PAT) assets from 908 Devices for a total of $70 million. This acquisition should be viewed as more than just a simple addition of technology; it
We are joined today by Ivan Kairatov, a seasoned biopharma expert with extensive knowledge in technology, innovation, and research and development within the industry. In this interview, we will discuss the ClaraTM 6 Well Cell Culture plates introduced by Porvair Sciences, focusing on their
The possibility of creating complex three-dimensional human tissues from diverse biological materials has always been an intriguing concept within medical research. The groundbreaking innovation known as the Electrospider, developed by Bio3DPrinting, a spinoff from Italy's University of Pisa,
The concept of using the body's own immune system to combat cancer, known as immunotherapy, has undergone significant evolution over the past decade. Initially deemed a novel approach for treating a limited patient demographic with advanced cancer types, immunotherapy now stands as a
The field of bioprinting is rapidly evolving, with bioinks playing a crucial role in the development of 3D printed living tissues. Bioinks, which incorporate live cells and bioactive molecules, are essential for creating tissue models that can revolutionize medicine, biology, and personalized
In the rapidly evolving landscape of biopharmaceutical manufacturing, capturing real-time data has become pivotal in optimizing bioreactor performance and producing high-quality products. Inline monitoring technologies are at the forefront of this transformation, offering real-time surveillance and
